Pharma M&A down to near 5 year low
Deals in 2017 are on pace for almost half the yearly totals of the past two years. Potential buyers await clarity surrounding tax reform.
top of page
Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
bottom of page